Divalproex Sodium Tablet, Delayed Release
Product Images NDC 68788-4079

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 68788-4079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Structure (Divalproex Sodium De Figure 1)

Structure (Divalproex Sodium De Figure 1)
FDA Label Image

Figure1 (Divalproex Sodium De Figure 2)

Figure1 (Divalproex Sodium De Figure 2)
FDA Label Image

Figure2 (Divalproex Sodium De Figure 3)

Figure2 (Divalproex Sodium De Figure 3)
FDA Label Image

Figure3 (Divalproex Sodium De Figure 4)

Figure3 (Divalproex Sodium De Figure 4)
FDA Label Image

Figure4 (Divalproex Sodium De Figure 5)

Figure4 (Divalproex Sodium De Figure 5)
FDA Label Image

Divalproex Sodium Dr 250mg (Divalproex Sodium De Figure 7)

Divalproex Sodium Dr 250mg (Divalproex Sodium De Figure 7)
This text provides information on Divalproex Sodium DR 250, a generic for Depakote DR. It includes details such as dosage, manufacturer, and storage instructions. It emphasizes caution in the transfer of the drug, highlighting it should only be used by the patient for whom it was prescribed. The drug is described as an enteric-coated tablet, oval-shaped and brown in color, with specific imprints for identification. It also mentions storage guidelines and warning statements regarding its use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.